Safety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine
Clinical trial NCT06181292 · COMPLETED
Trial details
- NCT number
- NCT06181292
- Sponsor
- Hipra Scientific, S.L.U
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-15
- Primary completion
- 2024-06-17
- Enrollment
- 913
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.